Understanding how aortic stenosis progresses and who is at risk
Official title: Evaluation of Immunologic and Image Morphologic Parameters to Predict Disease Progression in Patients With Moderate Aortic Valve Stenosis
Run by Heinrich-Heine University, Duesseldorf · NCT05851209 · Data updated 2026-11-12
This study tests whether imaging, genetic, and immune markers can predict which people with moderate aortic valve narrowing will quickly develop severe disease.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 938 (estimated) |
| Sponsor | Heinrich-Heine University, Duesseldorf Academic / other |
| Locations | 3 sites (Bonn and 2 other locations) |
| Status | Recruiting |
| Started | July 1, 2023 |
| Main results expected | July 2026 |
| Study ends | July 2031 |
| Registry record updated | June 30, 2026 |
| Trial ID | NCT05851209 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with acquired moderate tricuspid aortic valve stenosis under regular cardiology care.
✕Probably not a fit
Patients with mild or very advanced disease, bicuspid valves, or contraindications to MRI/CT may not benefit from the study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study follows a large cohort of adults with moderate aortic stenosis to identify biomarkers and imaging features that predict progression to severe disease. Researchers will analyze morphological, functional, genetic, and immunological data to see which factors best forecast worsening valve function. The goal is to identify high-risk patients who might benefit from earlier intervention and to explore options to slow progression. The study builds on previous work showing inflammation and calcification play roles in aortic valve disease.
Why it matters
Potential benefit: If successful, the study could improve early risk stratification and inform timing of treatment to prevent adverse outcomes.
How similar studies have gone: Prior work suggests inflammatory and imaging markers can relate to disease progression, supporting the approach but the specific predictive model is being tested here.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * The patient has an acquired (tricuspid) moderate aortic valve stenosis, which is the reason for regular outpatient cardiological care. * The subject has been informed verbally and in writing about the study and has given written consent to participate in this study. * Age \> 18 years Exclusion Criteria: * The subject has contraindications for the performance of a magnetic resonance imaging or computed tomography (e.g., severe arrhythmias , contrast agent intolerance, a pacemaker, or severe renal insufficiency or severe renal insufficiency or claustrophobia). * Presence of only mild or already high-grade acquired tricuspid Aortic valve stenosis * Patient with bicuspid aortic valve * Inability to follow the instructions of study personnel * Lack of written informed consent
Where it's running
-
University-Hospital Bonn
Bonn, Germany Recruiting -
University Hospital Cologne
Cologne, Germany Recruiting -
University-Hospital Düsseldorf Division of Cardiology, Pulmonary Disease and Vascular Medicine
Düsseldorf, Germany Recruiting
Study contacts
- Study coordinator: Tobias Zeus, MD
- Email: zeus@med.uni-duesseldorf.de
- Phone: +4921118800
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Exercise and nutrition support before and after TAVI for older adults with aortic stenosis
This trial tests whether a personalized exercise program plus protein and iron supplements before and after a transcatheter valve replacement can help older adults with aortic stenosis recover better than standard care.
-
Association Between Aortic Valve Area Changes and Pulmonary Congestion After TAVI
This study tests whether improvements in aortic valve opening after TAVI relate to reductions in lung congestion measured by ultrasound in adults with severe aortic stenosis.
-
Systematic 14-day ambulatory heart monitoring after TAVI
After TAVI, patients with certain heart conduction abnormalities will try 14 days of wearable ECG monitoring to see if it lowers the chances of sudden death, symptomatic heart rhythm problems, or stroke within a year compared to standard follow-up.
-
Echo-AVCS: Drawing AI-powered clues from heart scans to confirm severe aortic stenosis
This study tests an AI-based echocardiography score to help confirm severe aortic stenosis in adults who are also getting CT calcium scoring.
-
TAVI without on-site heart surgery: can selected centers do it safely?
This trial tests whether transcatheter aortic valve implantation can be done safely in certain hospitals that don’t have on-site cardiac surgery, for patients with severe aortic stenosis who are appropriately selected.
-
Willem AI for early detection of aortic stenosis from a 12‑lead ECG
This project will test whether the Willem AI can detect aortic stenosis from routine 12‑lead ECGs in adults.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.